Home › Cystic Fibrosis › Kansas › Kansas City
Cystic Fibrosis clinical trials in Kansas City, KS
13 studies for Cystic Fibrosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
RecruitingPhase 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RecruitingPhase 1Healthy volunteers welcome
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
RecruitingObservational study
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
RecruitingPhase 1/2
- University of Kansas Medical Center, Kansas City
About Cystic Fibrosis
Cystic fibrosis (CF) is an inherited disease of the mucus and sweat glands. The symptoms and severity of CF can vary. Get the facts.
More about Cystic Fibrosis on MedlinePlus
Cystic Fibrosis trials in other cities
- Boston, MA17 studies
- Birmingham, AL16 studies
- Philadelphia, PA15 studies
- Seattle, WA12 studies
- Baltimore, MD12 studies
- Denver, CO11 studies
- Pittsburgh, PA11 studies
- Dallas, TX11 studies
- Cincinnati, OH10 studies
- Los Angeles, CA9 studies
- Aurora, CO9 studies
- Charleston, SC8 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
- Asthma8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.